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1.1. A solid-phase approach to novel aza-diketopiperazines (Aza-DKP)
Very many biologically active compounds are heterocyclic in
nature, and amongst these the diketopiperazine (DKP) occupies a
special place as it marks the intersection of peptides and heterocy-
cles and represents the smallest possible cyclic peptide. DKPs have
been shown to have a range of pharmacological activity including
the modulation of GPCRs such as calcium channels, opioid, GAB-
Aergic, seritonergic and oxytocin receptors. A DKP is also at the
heart of the PDE5 inhibitor drug Cialis. One modiﬁed DKP that
has been very poorly explored to date is the 1,2,4-triazine-3,6-
dione (aza-DKP) which can be considered a DKP with one alpha
centre replaced by a planar nitrogen. There are very few examples
of the synthesis or screening of this heterocycle. A recent paper de-
scribes the solution-phase and solid-phase synthesis of aza-DKPs,
and extends this approach to the preparation of a library of com-
pounds suitable for biological screening.1
The aza-DKP structure is attractive for drug discovery, as it is a
low molecular weight heterocycle, containing ﬁve heteroatoms,
and has a number of hydrogen-bond donors and acceptors that
readily puts it within Lipinski ‘Rule of 5’ space. The preparation
of the heterocyclic system was successfully explored in solution
and then the approach was extended to a library of derivatives
made on a solid support. This approach was optimised by the syn-
thesis of 2,4,5-tribenzyl-1,2,4-triazine-3,6-dione starting from
commercially available Fmoc-L-phenylalanine-Wang-polystyrene
resin (1).
After removal of the Fmoc protective group, reductive amina-
tion step with benzaldehyde in trimethylorthoformate followed
by reduction of the imine with sodium cyanoborohydride gave
the secondary amine intermediate 2. The semi-carbazide interme-
diate (3) was prepared in 61% yield by using bis(trichloro-
methyl)carbonate (BTC) as a phosgene equivalent to acylate the
amine followed by reaction with an excess of the tert-butylcarbaz-
ate 4 overnight in THF. An unprecedented acid-catalysed cyclisa-
tion of the solid-supported semi-carbazide 3, in triﬂuoroacetic
acid over one hour, gave the product aza-DKP (5) with concomitant
release from the solid support.http://dx.doi.org/10.1016/j.comche.2012.05.002
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ogy was used for the synthesis of a small library using a range of
Fmoc-protected L-amino acids, and a range of different aldehydes
in the ﬁrst reductive amination step. The ultimate library com-
prised products in >60% purity and yields that varied from 9% to
78%. The process was demonstrated to be compatible with hydro-
phobic, polar, cationic or anionic amino acids. In addition, the use
of a propargyl-derived triazinedione permitted subsequent 1,3-
dipolar cycloadditions to further add diversity to the library by
the addition of a triazole ring.
This approach has demonstrated a rapid approach to the under-
explored class of 2,4,5-trisubstituted-1,2,4-triazine-3,6-diones, and
will facilitate the screening of this structural class for the discovery
of novel biologically-active compounds.2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
The development of an improved methodology for the iterative
solid-phase synthesis of para- and meta-arylopeptoids (oligomeric
N-substituted aminomethyl benzamides) using benzoyl chloride
building blocks has been described. This methodology has enabled
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chains,which allows for complete control over the amide conforma-
tion: the tert-butyl results in a 100% cis amide conformation while
the phenyl side chain results in a 100% trans amide conformation.2
2.2. Solution-phase synthesis
Libraries of skeletally diverse potential bioactive polycyclic/spi-
rocyclic heterocyclic compounds have been synthesised through a
multi-component reaction using novel heterocyclic active methy-
lene compound 4-hydroxy-1,3-dimethyl-1H-pyrazolo[3,4-b]pyri-
dine-6(7H)-one as one of the building blocks. The protocol can be
considered to be an efﬁcient and eco-friendly strategy for diversity
oriented synthesis.3
Amulti-component reaction of 2-alkynylbenzaldehyde, 4-meth-
ylbenzenesulphonohydrazide, carbodiimide, and bromine has been
reported, which generates 1-(4-bromoisoquinolin-1-yl)guanidines
in good yields under mild conditions. The products could be further
elaborated via a palladium-catalyzed Suzuki–Miyaura coupling
reaction, leading to the diverse 1-(isoquinolin-1-yl)guanidines.
Library construction and subsequent biological evaluations are in
progress.4
2.3. Scaffolds and synthons for combinatorial libraries
TMSOTf-promoted glycosidation of 2-azido-4,6-O-benzylidene-
2-deoxygalactosyl diphenyl phosphates with Fmoc-protected ser-
ine and threonine derivatives has given glycosyl amino acids in
high yields and with excellent levels of a-selectivity. The synthetic
utility of this glycosidation method was demonstrated by a stere-
oselective synthesis of mucin-type glycopeptide building blocks,
which are suitable for Fmoc-based solid-phase synthesis of O-
glycopeptides.5
2.4. Solid-phase supported reagents
No papers this month.
2.5. Novel resins, linkers and techniques
(2,6-Dichloro-4-methoxyphenyl)(2,4,6-trichlorophenyl) methoxy-
methyl chloride shows a signiﬁcant relative stability and reacts
with the uridine ureido nitrogen in the presence of DBU to form
the corresponding protected uridine in 95% yield. The MDPM-pro-
tected uridines are stable to a wide variety of conditions used for
the synthesis of analogues of capuramycin and muraymycins.
The MDPM protecting group can conveniently be deprotected by
using 30% TFA in CH2Cl2, and in addition, polymer-bound MDPM-
Cl is useful for immobilisation of uridine derivatives.6
2.6. Library applications
The generation of novel CRTH2 ligands in heavily congested
chemical space, by de novo design of libraries has been disclosed.
Novel compounds across seven libraries were synthesised, and
more than 100 of these compounds showed binding potency
<3 lM against CRTH2, with the most potent being 247 nM.7
A bio-inspired investigation of the reactions of substrates with
VOF3 and PIFA [phenyliodine(III) bis(triﬂuoroacetate)] has led to
a library of colchicine-like compounds. Biological evaluation
revealed that some of the synthesised products had signiﬁcant
cytotoxic properties against the colon cancer cell line HT-29.8
High throughput screening to identify inhibitors of the mTOR
kinase has revealed a sulphonyl-morpholino-pyrimidine as an
attractive starting point. The compound displayed good physico-
chemical properties and selectivity over related kinases such asPI3 Ka. Library preparation of related analogues has allowed the
establishment of additional SAR understanding and in particular
the requirement for a key hydrogen bond donor motif at the 4-
position of the phenyl ring. Isosteric replacement of the indole
functionality led to the identiﬁcation of urea compounds that show
good levels of mTOR inhibition in both enzyme and cellular
assays.9
A small library of phenolic natural compounds belonging to dif-
ferent chemical classes has been screened against a panel of targets
involved in the genesis and progression of cancer. The re-investiga-
tion of their potential activity was achieved through the Inverse
Virtual Screening approach. The normalisation of the predicted
binding energies permitted the selection of promising compounds
on deﬁnite targets, avoiding the selection of false positive results.
In vitro biological tests revealed the inhibitory activity of xan-
thohumol and isoxanthohumol on PDK1 and PKC protein kinases.10
The preparation of three novel series of compounds based on
the structure of goniothalamin, a natural styryl lactone has been
described. Goniothalamin has been found to display cytotoxic
and antiproliferative activities against a variety of cancer cell lines,
and a focused library of 29 novel analogues was prepared and eval-
uated against seven human cancer cell lines.11References
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